Alabama Doctor Telemedicine Fraud: Telemarketing Calls Became Medical Orders

An Alabama doctor’s telemedicine fraud scheme generated over $2.7 million in Medicare claims by turning telemarketing calls into signed orders for medically unnecessary durable medical equipment and genetic testing, according to the Justice Department’s account of the criminal case. The doctor generally did not contact the Medicare beneficiaries himself and had no provider-patient relationship with them. Suppliers and laboratories then used his signed orders to submit Medicare claims. For someone inside the business, the revealing handoff is where information from a sales call became a doctor’s medical documentation.

How Prepopulated Orders Reached Medicare

According to the Justice Department’s account of the criminal case in federal court in Boston, the doctor worked with telemedicine companies to sign medical documentation, including orders, from December 2018 through March 2021. The orders were prepopulated from telemarketing calls to Medicare beneficiaries. The information reached the doctor already arranged for his signature.

The medical decision was supposed to sit between the sales call and the order. Instead, the doctor signed documentation prepared from the call, generally without contacting the beneficiary. His signature then traveled to the equipment supplier or laboratory that submitted the Medicare claim. The clinical relationship was missing, but the paperwork reached the biller.

The doctor pleaded guilty to health care fraud in October 2025. The scheme put medically unnecessary equipment and testing on Medicare’s tab, at taxpayers’ expense.

Durable Medical Equipment and Genetic Testing Shared the Same Entry Point

The Alabama case involved both durable medical equipment suppliers and laboratories receiving signed orders. That makes the order’s destination important: the same missing clinical relationship could sit upstream of an equipment claim or a laboratory claim.

The Justice Department described the genetic testing as primarily intended to detect mutations associated with a higher risk of certain cancers. Its account identified both the equipment and the testing as medically unnecessary.

The industry structure helps explain why the signature has value. In its July 20, 2022 Special Fraud Alert, the Department of Health and Human Services Office of Inspector General described companies recruiting patients and practitioners, supplying information, paying for reviews or signatures, and transferring resulting orders to downstream buyers. An order can be the output of the telemedicine business, with another business submitting the Medicare bill.

When a Portal Supplies the Medical Story

In a separate civil case, a physician admitted approving genetic tests through MySpecialistMD, generating signed medical-necessity documents without a treating relationship. The parallel to the Alabama case is the gap between the signed medical account and the care the patient actually received.

The Staffing Company Behind the Approval

In a separate civil settlement, Jackson & Coker LocumTenens admitted to a staffing arrangement with fees tied to approved orders. Its role connected the doctor’s signature to downstream Medicare claims even though the staffing company did not itself bill Medicare.

What Evidence Is Needed to Report Fraud?

For prepopulated-order fraud, useful evidence connects the original beneficiary information, the clinician’s actual contact, the signed medical assertions and the resulting claim. Our whistleblower experts work with insiders to connect those parts of the transaction and identify what their firsthand knowledge explains.

In the Alabama case, the government described orders generated from telemarketing calls and a doctor who generally did not contact the beneficiaries himself. An insider who knows how the company prepared those orders can explain the gap between the medical account on paper and the work actually done.

The 2024 Rutgers University Law Review paper Plausible Cause: Connecting the FCA and AKS in the Context of Health Care Fraud points to the business arrangements behind the claims. Citing the inspector general’s alert, it highlights companies that supply only one product or type of product and do not give practitioners the information needed for patient follow-up. That perspective fits the question raised here: was the business set up to deliver care or to produce orders?

You Know What Happened Before the Signature

If you saw telemarketing information become medical orders without the patient care those orders represented, speak to one of our Whistleblower Experts about how those orders were made. We work with you to build the case around the orders, the business arrangements and the Medicare claims, and bring in telehealth fraud whistleblower lawyers who understand equipment and laboratory billing. We stay with you through the process to build your strongest telehealth fraud whistleblower case. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.